Wan Ling Tan

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis

Aaron C. Tan, Gillianne Lai, Gek San Tan et al. · Lung Cancer · 2019 · 124 citations

Medicine, Oncology, Pharmacoeconomics +17

Clonal <i>MET</i> Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer

Gillianne Lai, Tse Hui Lim, John Lim et al. · Journal of Clinical Oncology · 2019 · 117 citations

Medicine, Cancer Biology, Oncology +17

EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients

Natalia Sutiman, Shao Weng Tan, Eng Huat Tan et al. · Journal of Thoracic Oncology · 2016 · 74 citations · Full text

Life Sciences, Genetics, Oncology +8

Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer

Stephanie P.L. Saw, Siqin Zhou, Jianbin Chen et al. · JAMA Network Open · 2021 · 56 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC

Aaron C. Tan, A. Seet, Gillianne Lai et al. · Journal of Thoracic Oncology · 2020 · 54 citations · Full text

Medicine, Molecular Genetics, Oncology +17